Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Long-term consequences of the misuse of ivermectin data. Lancet Infect Dis.

Investigación y Educación

Alvarez-Moreno C, Cassell JA, Donkor CM, Head MG, Middleton J, Pomat W, Saka B, Yirgu R.  18/10/2021

Ivermectin is an oral anti-infective medicine that is integral to neglected tropical disease programmes. It is safe and effective for the treatment and control of lymphatic filariasis, scabies, and onchocerciasis, sometimes as part of a mass drug administration, as recognised in the WHO road map for neglected tropical diseases 2021–30.1 The WHO essential medicines list provides recommendations for minimum medicine needs for a basic health-care system, which includes ivermectin as an anthelmintic, antifilarial, and antiectoparasitic treatment.2
There has been a groundswell of opinion across several countries that ivermectin might be useful in reducing the symptoms of and mortality due to COVID-19, with many citing meta-analyses that infer positive effects;3 however, these conclusions appear to be unreliable. On March 31, 2021, WHO advised that ivermectin should only be used within clinical trials and not as part of routine clinical practice.4 This advice was followed by the manufacturer, Merck, that stated on Feb 4, 2021, that there is “no meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease”.5 Despite this, ivermectin is being routinely used in some Latin American settings amid recommendations from some governments and health professionals.

Read full article

Artículos que te pueden interesar

Enfermedades infecciosas

Imaging manifestations of pulmonary melioidosis: A case series. Radiologia (Engl Ed).

Leer más

Enfermedades infecciosas

Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial. EClinicalMedicine.

Leer más

Enfermedades infecciosas

Implications of Antibiotic Use During the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America. Antibiotics

Leer más